Add To Watchlist
Share URL
About The Company
CEO
Mr. Robert Michael Dudley
Market Cap
5.30 Million USD
Sector
Healthcare
Website
https://www.transcodetherapeutics.comDescription
TransCode Therapeutics, Inc.
Read More
Overview
Value
1
Growth
31
Health
43
Management
42
Analyst Opinion
57
Total
35
All Scores Out Of 100
Best Features
- Has a low level of debt
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders
- No margin of safety at their current market price
- Poor earnings and cashflow growth 0
Latest News

10 Penny Stocks Under $1 To Watch Now, Time To Buy?
PennyStocks | 19:22 Fri 3 Mar 2023
Read More →

7 Penny Stocks Under $1 To Watch Now, Time To Buy?
PennyStocks | 19:48 Wed 1 Mar 2023
Read More →

4 Penny Stocks Under $1 To Watch Now, Time To Buy?
PennyStocks | 23:40 Tue 28 Feb 2023
Read More →

RNAZ Stock: 4.96% This Week Explanation
Pulse2 | 03:52 Tue 21 Feb 2023
Read More →
Market Peers
RNAZ
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-620.66%
Revenue Growth (5 Year Average)
N/A
Ratings Consensus
Neutral
Share Buybacks
-1.63%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/A✘
Current Price: 0.3 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-352.98%
PE/Earnings Growth
N/A
Price/Book
0.61x
Growth
Growth Score
31
- ✔ Revenue growth has improved this yeara
- ✔ 5 Year Average Earnings growth of 14.90% is higher than the market average (14.48%)
- ✘ 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of -2.33% is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
N/A
Earnings Growth
14.90%
Cashflow Growth
-2.33%
Health
Health Score
43
Altman Z Score
N/A
Piostroski Score
N/A
Debt/Equity
N/Ax
Current Assets/Liabilities
3.07x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
N/Ax
Management
Management Score
42
Average Buybacks/Dilution
-1.63%
Recent Buybacks/Dilution
21.93%
5 Year Price Volitility
45.60%
Return On Assets
-43.46%
Return On Capital Employed
-26.80%
Return On Equity
-63.34%
Return On Free Cashflow
71.37%
Return On Investments
N/A
Analysts
Analyst Opinion
57
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
TransCode Therapeutics, Inc.
Currency
USD
Beta
0
Vol Avg
3519383
Ceo
Mr. Robert Michael Dudley
Cik
0001829635
Cusip
89357L105
Exchange
NASDAQ Capital Market
Full Time Employees
8
Industry
Biotechnology
Sector
Healthcare
Ipo Date
2021-04-28
Address
6 Liberty Square
City
Boston
State
MA
Country
US
Zip
02109
Phone
857-837-3099
All financial data provided by FMP